CEP
IRMD icon

Chicago Equity Partners’s iRadimed IRMD Stock Holding History

Chicago Equity Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,900
Closed -$278K – 764
2019
Q4 		$278K Sell
11,900
-8,100
-41% -$189K 0.02% 767
2019
Q3 		$420K Hold
20,000
– – 0.02% 713
2019
Q2 		$409K Hold
20,000
– – 0.02% 743
2019
Q1 		$562K Buy
+20,000
New +$523K 0.02% 643

Other funds holding IRMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Chicago Equity Partners's IRMD Position: Q1 2020 in Review

Chicago Equity Partners sold out of iRadimed (IRMD) in Q1 2020, closing a stake of 11,900 shares — an estimated $278K sold.

Chicago Equity Partners first reported a position in IRMD in Q1 2019 and held it in 4 quarters. The position peaked at $562K in Q1 2019. 69 funds tracked by Wall St. Rank hold IRMD as of Q1 2020.

  • Chicago Equity Partners reported no remaining iRadimed position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 11,900 iRadimed shares in Q1 2020, an estimated $278K.
  • Chicago Equity Partners first reported a position in iRadimed in Q1 2019 and held it in 4 quarters.
  • Chicago Equity Partners's iRadimed position peaked at $562K in Q1 2019.
  • 69 funds tracked by Wall St. Rank held iRadimed as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.